Covering Import Supervision, Drug Regulation, Anti-Dumping, Competition Compliance, Compliance Program. Insights on Indonesia’s competition compliance enforcement, drug import regulation amendments, anti-dumping duty continuations in Malaysia, and US tariff proposals on Philippine exports. Covers Import Supervision, Drug Regulation, Anti-Dumping, Competition Compliance, and Compliance Programs.
Regulatory news, updates, and insights for countries in the ASEAN region presented by the Carver Agents team
Welcome to Carver's ASEAN Regulatory Updates for June 07, 2026.
In Indonesia, the Indonesian Competition Commission, known as KPPU, has issued multiple compliance program approvals and enforcement decisions targeting companies' adherence to competition laws. These actions emphasize the importance of implementing and maintaining competition compliance programs, particularly regarding service delivery and market conduct. KPPU also clarified requirements for businesses participating in the Competition Compliance Program. Companies must register and document their programs in the Indonesian language. Furthermore, mergers and acquisitions exceeding Rp 2.5 trillion in assets or Rp 5 trillion in sales must notify KPPU within 30 working days of legal effectiveness. Banking sector businesses face a higher asset threshold of Rp 20 trillion for notification.
KPPU continues to evaluate mergers, consolidations, and acquisitions with a focus on preventing substantial lessening of competition and monopolistic practices. Notifications are mandatory post-transaction for qualifying deals, with voluntary pre-merger consultations encouraged to assess competition risks. KPPU conducts both administrative verification and substantive assessments, including initial and comprehensive evaluations.
Additionally, several companies in Indonesia have been banned by KPPU from participating in government procurement tenders for periods ranging from one to two years due to violations of healthy competition principles. These bans apply to tenders funded by the national and regional budgets, known as APBN and APBD, respectively.
On the regulatory front, Indonesia’s Food and Drug Supervisory Agency, Badan Pengawas Obat dan Makanan, has opened a public consultation on a draft regulation amending Regulation Number 27 of 2022 concerning the supervision of drug and food importation into Indonesia. The consultation period ends on June 19, 2026, with compliance expected by June 6, 2026. This amendment affects import controls on drugs, traditional medicines, health supplements, cosmetics, and processed foods.
In trade developments, the Regional Comprehensive Economic Partnership, or RCEP, has become effective. This agreement creates the world’s largest free trade area, including China, ASEAN countries, Japan, Korea, Australia, and New Zealand. The agreement covers trade in goods, services, investment, intellectual property, and more. Businesses in member countries must adhere to tariff commitments, rules of origin, customs procedures, sanitary and phytosanitary measures, and trade remedies as specified in the agreement annexes.
In Malaysia, the Ministry of Commerce of China has announced that Daicel HPP Malaysia Sdn. Bhd. will inherit an 8.0 percent anti-dumping duty rate previously applied to Polyplastics Asia Pacific Sdn. Bhd. Similarly, KOLON INDUSTRIES, INC. will inherit a 6.2 percent anti-dumping duty rate previously applied to KOLON ENP, INC. These measures, effective from June 5, 2026, relate to imports of copolymer polyoxymethylene originating from South Korea, Thailand, and Malaysia, ensuring continuity of anti-dumping obligations following corporate restructuring.
Turning to the Philippines, the United States Trade Representative has proposed additional tariffs of up to 12.5 percent on certain Philippine exports. This action follows allegations that the Philippines has failed to enforce prohibitions on forced labor in imports. To avoid these tariffs, the Philippines must impose and effectively enforce a forced-labor import ban. Comments and proposed responsive actions must be submitted to the USTR by July 7, 2026.
Finally, in Indonesia, the Indonesia Deposit Insurance Corporation, known as LPS, has introduced a formal objection process for depositors disputing the deposit guarantee status of PT BPR Pembangunan Nagari. Depositors have 180 calendar days from the announcement date to submit written objections with supporting evidence. Objections can be submitted via letter or through the LPS online application, accompanied by identity proof, deposit ownership documentation, and other relevant materials.
That wraps up today's regulatory updates. Visit carveragents.ai for more information.